Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Encompass Health Corp Director's Dealing 2021

Mar 4, 2021

30484_dirs_2021-03-04_1b713a47-9ada-475d-96a2-ef05c6e91f70.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Encompass Health Corp (EHC)
CIK: 0000785161
Period of Report: 2021-03-02

Reporting Person: Anthony April Kaye Bullock (CEO & President, Home Health)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-02 Non-qualified Stock Option (Right to Buy) $80.40 A 9375 Acquired 2031-03-02 Encompass Health Common Stock (9375) Direct

Footnotes

F1: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 2, 2022.